Medical Grand Rounds - Normal and Perimenopause and Menopause

Friday, February 19, 2021 | 12 p.m. - 1 p.m.
Microsoft Teams

Presenter: Anita L. Nelson, MD, Professor and Chair, Department of Obstetrics and Gynecology, Western University of Health Sciences, College of Osteopathic Medicine of the Pacific and Medical Director, Research Division, Essential Access Health, Los Angeles, CA

At the conclusion of this activity, participants should be able to:

  • Describe how to counsel women about endocrinologic changes that occur during perimenopause and menopause.
  • Identify any differences seen in different ethnic groups – both physiologically and culturally.
  • Describe how those changes can affect current symptomatology and long-term health.
  • Outline therapeutic options from lifestyle changes to over-the-counter medications to prescription drugs (nonhormonal and hormonal) for each of the manifestations of perimenopause and menopause.

Date:  Friday, February 19, 2021
Time:  12 p.m.
Location: Microsoft Teams - E-mail to be included

This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Professionals.

Accreditation Statement
“The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”

Designation Statement
“The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”

Disclosure/Conflict of Interest Statement
“Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).” The presenting faculty has indicated that she may have a conflict of interest related directly or indirectly to her presentation. The presenter has indicated she receives honoraria from Agile, Bayer, Merck and TherapeuticsMD for her role on their speaker’s bureau. She also is a consultant and sits on the advisory board for Agile, AMAG, American Regent, Bayer, Mayne, Merck, Myovant, and TherapeuticsMD. In addition, she has received grants for research from Merck and Sebela Pharma. Her presentation has been reviewed prior to today’s presentation by the MGR Program Director in which no commercial bias was perceived.